ARHGAP25 and osteosarcoma: found that ARHGAP25 exerted an inhibitory effect on MG63 cell proliferation, migration, and progression of epithelial–mesenchymal transition (EMT) and could work as a predictive biomarker for osteosarcoma metastasis (40).